Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk (NVO), the company behind Ozempic and Wegovy, announced that it will invest 6.4 billion reais (about $1.09 ...

The Danish pharmaceutical company behind obesity drug Wegovy, Novo Nordisk, plans to invest US$1.09bn in expanding its ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to ...

On Monday, Novo Nordisk A/S (NYSE:NVO ... Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become ...

Novo Nordisk (NVO), the company behind Ozempic ... Reinaldo Costa, the vice president of the Montes Claros factory, said this expansion will significantly increase the plant’s output, although ...

“Something that sells for $88 in London sells for $1,300 here, made in the same factory by the same company ... whose president is Novo Nordisk CEO Lars Fruergaard Jørgensen, said in a statement.

For more than three decades, the pharmaceutical sector has been protected from tariffs by a World Trade Organization ...

It takes three to five years to build a drug factory, she said. Generics have been a significant ... intravenous antibiotics and other hospital treatments in particular. Just two companies, Novo ...

Roofing-products manufacturer IKO North America has been on a factory-building spree in the U.S., with one plant completed and four more under construction. After President Trump launched a barrage of ...